中文簡(jiǎn)介

編輯委員會(huì)由ALS和FTD的主要意見領(lǐng)袖組成。肌萎縮側(cè)索硬化癥和額顳葉變性旨在傳播ALS和FTD發(fā)病機(jī)制和治療方面的新進(jìn)展，并提高人們對(duì)這些破壞性的、往往未得到充分認(rèn)識(shí)的疾病的認(rèn)識(shí)。編輯鼓勵(lì)提交有關(guān)ALS、額顳葉癡呆及相關(guān)疾病的原始研究、病例報(bào)告和簡(jiǎn)短報(bào)告，包括基礎(chǔ)科學(xué)、遺傳學(xué)、新療法、臨床試驗(yàn)、流行病學(xué)、臨床神經(jīng)生理學(xué)以及其他臨床和科學(xué)方面的研究。功能包括:深入的評(píng)論原始研究基礎(chǔ)科學(xué)流行病學(xué)臨床試驗(yàn)護(hù)理問題道德及法律問題衛(wèi)生經(jīng)濟(jì)學(xué)案例報(bào)告對(duì)點(diǎn)的辯論對(duì)應(yīng)書評(píng)ALS中心報(bào)告

投稿網(wǎng)址：https://mc.manuscriptcentral.com/als

英文簡(jiǎn)介

The Editorial Board comprises key opinion leaders in ALS and FTD. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration aims to disseminate information on new developments in the pathogenesis and management of ALS and FTD, and enhance awareness of these devastating and often under-recognised disorders. The Editors encourage submission of original research, case reports and short reports on all aspects of ALS, frontotemporal dementia and related conditions, including basic science, genetics, new treatments, clinical trials, epidemiology, clinical neurophysiology, and other clinical and scientific aspects.Features include: In-depth reviews Original research Basic science Epidemiology Clinical trials Care issues Ethics and legal issues Health economics Case reports Point-counterpoint debate Correspondence Book reviews ALS centre reports